Todays Report: The Credit Suisse Group AG Analysts Give Mead Johnson Nutrition Co. (MJN) a $95.00 Price Target

The Credit Suisse Group AG Analysts Give Mead Johnson Nutrition Co. (MJN) a $95.00 Price Target

Mead Johnson Nutrition Co. (NYSE:MJN) received a $95.00 price objective from equities researchers at Credit Suisse Group AG in a research report issued to clients and investors on Wednesday. The firm currently has a a “buy” rating on the stock. Credit Suisse Group AG’s price target would suggest a potential upside of 18.47% from the stock’s previous close.

Other research analysts have also issued reports about the stock. Goldman Sachs Group Inc. lowered their price objective on shares of Mead Johnson Nutrition from $96.00 to $85.00 and set a “neutral” rating on the stock in a research note on Tuesday, September 27th. Credit Agricole SA upgraded shares of Mead Johnson Nutrition from an “underperform” rating to an “outperform” rating and set a $96.00 price objective on the stock in a research note on Wednesday, August 3rd. Deutsche Bank AG set a $88.00 price objective on shares of Mead Johnson Nutrition and gave the stock a “hold” rating in a research note on Sunday, July 24th. BMO Capital Markets reiterated an “outperform” rating and issued a $97.00 price target on shares of Mead Johnson Nutrition in a research note on Monday, August 1st. Finally, Susquehanna reiterated a “hold” rating and issued a $95.00 price target on shares of Mead Johnson Nutrition in a research note on Monday, August 29th. One research analyst has rated the stock with a sell rating, six have given a hold rating and six have given a buy rating to the company. Mead Johnson Nutrition has an average rating of “Hold” and an average target price of $94.33.

Shares of Mead Johnson Nutrition (NYSE:MJN) traded up 0.77% on Wednesday, reaching $80.81. 915,088 shares of the company’s stock were exchanged. The company has a market cap of $14.92 billion, a price-to-earnings ratio of 30.40 and a beta of 1.26. The firm’s 50-day moving average price is $79.94 and its 200 day moving average price is $84.66. Mead Johnson Nutrition has a 12 month low of $65.53 and a 12 month high of $94.40.

Mead Johnson Nutrition (NYSE:MJN) last issued its quarterly earnings results on Thursday, July 28th. The company reported $0.88 EPS for the quarter, topping the consensus estimate of $0.78 by $0.10. Mead Johnson Nutrition had a net margin of 13.28% and a negative return on equity of 194.30%. The firm had revenue of $941.50 million for the quarter, compared to analysts’ expectations of $967.25 million. During the same period in the previous year, the firm posted $0.76 EPS. The company’s revenue for the quarter was down 8.8% on a year-over-year basis. Equities research analysts predict that Mead Johnson Nutrition will post $3.48 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Monday, October 3rd. Investors of record on Monday, September 19th were paid a $0.4125 dividend. This represents a $1.65 annualized dividend and a yield of 2.06%. The ex-dividend date was Thursday, September 15th. Mead Johnson Nutrition’s payout ratio is 62.03%.

In related news, Director Kimberly A. Casiano sold 710 shares of the stock in a transaction that occurred on Monday, August 15th. The shares were sold at an average price of $89.75, for a total value of $63,722.50. Following the completion of the transaction, the director now owns 7,110 shares of the company’s stock, valued at approximately $638,122.50. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, SVP Graciela Monteagudo sold 45,873 shares of the stock in a transaction that occurred on Friday, August 5th. The shares were sold at an average price of $87.64, for a total transaction of $4,020,309.72. Following the completion of the transaction, the senior vice president now directly owns 13,800 shares of the company’s stock, valued at approximately $1,209,432. The disclosure for this sale can be found here. 0.50% of the stock is currently owned by corporate insiders.

Institutional investors have recently modified their holdings of the stock. FMR LLC increased its position in shares of Mead Johnson Nutrition by 11.8% in the second quarter. FMR LLC now owns 13,045,067 shares of the company’s stock valued at $1,183,840,000 after buying an additional 1,378,877 shares during the last quarter. Vanguard Group Inc. increased its position in Mead Johnson Nutrition by 1.4% in the second quarter. Vanguard Group Inc. now owns 11,547,883 shares of the company’s stock valued at $1,047,971,000 after buying an additional 154,730 shares during the last quarter. American Century Companies Inc. increased its position in Mead Johnson Nutrition by 15.2% in the second quarter. American Century Companies Inc. now owns 5,544,545 shares of the company’s stock valued at $503,167,000 after buying an additional 732,011 shares during the last quarter. BlackRock Institutional Trust Company N.A. increased its position in Mead Johnson Nutrition by 1.1% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 5,027,781 shares of the company’s stock valued at $456,271,000 after buying an additional 56,360 shares during the last quarter. Finally, Waddell & Reed Financial Inc. increased its position in Mead Johnson Nutrition by 47.0% in the second quarter. Waddell & Reed Financial Inc. now owns 4,274,094 shares of the company’s stock valued at $387,874,000 after buying an additional 1,367,163 shares during the last quarter. 96.93% of the stock is owned by institutional investors and hedge funds.

Mead Johnson Nutrition Company Profile

Related posts

Leave a Comment